乳腺癌前哨淋巴结活检规范化操作指南(2022精要版)

2022-11-30 中国抗癌协会 中国肿瘤临床 发表于上海

中国抗癌协会乳腺癌专业委员会组织业内专家依据循证医学方法制定《乳腺癌前哨淋巴结活检规范化操作指南》,内容涉及SLNB适应证、示踪剂选择与应用、组织标本处理、腋窝SLNB、新辅助治疗与SLNB、内乳SL

中文标题:

乳腺癌前哨淋巴结活检规范化操作指南(2022精要版)

发布机构:

中国抗癌协会

发布日期:

2022-11-30

简要介绍:

乳腺癌是女性最常见的恶性肿瘤,区域淋巴结状况作为重要的预后指标,可指导患者的淋巴结分期,并对后续治疗策略产生影响。前哨淋巴结活检术(sentinel lymph node biopsy,SLNB)标志着乳腺癌淋巴结外科处理进入微创时代,但其安全有效替代腋窝淋巴结清扫术应建立在规范化操作前提下。中国抗癌协会乳腺癌专业委员会组织业内专家依据循证医学方法制定《乳腺癌前哨淋巴结活检规范化操作指南》,内容涉及SLNB适应证、示踪剂选择与应用、组织标本处理、腋窝SLNB、新辅助治疗与SLNB、内乳SLNB。本指南将为乳腺癌相关医务工作者的临床实践提供有益指导和参考。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=乳腺癌前哨淋巴结活检规范化操作指南(2022精要版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=e7a731c0028519ed, title=乳腺癌前哨淋巴结活检规范化操作指南(2022精要版), enTitle=, guiderFrom=中国肿瘤临床, authorId=0, author=, summary=中国抗癌协会乳腺癌专业委员会组织业内专家依据循证医学方法制定《乳腺癌前哨淋巴结活检规范化操作指南》,内容涉及SLNB适应证、示踪剂选择与应用、组织标本处理、腋窝SLNB、新辅助治疗与SLNB、内乳SL, cover=https://img.medsci.cn/20221209/1670591485629_1608702.jpg, journalId=0, articlesId=null, associationId=18, associationName=中国抗癌协会, associationIntro=中国抗癌协会是中国科学技术协会主管、中华人民共和国民政部注册登记、具有独立法人资格的肿瘤学科唯一的国家一级学会。成立以来积极开展肿瘤学科的临床与基础性研究,创建肿瘤专业继续教育基地,创办多种形式的肿瘤学习培训班,积极推广新成果、新技术,举办国内外肿瘤学术会议,为国内外肿瘤研究者提供了广阔的学术交流平台,促进了我国肿瘤防治水平的提高。, copyright=0, guiderPublishedTime=Wed Nov 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">乳腺癌是女性最常见的恶性肿瘤,区域淋巴结状况作为重要的预后指标,可指导患者的淋巴结分期,并对后续治疗策略产生影响。前哨淋巴结活检术(sentinel lymph node biopsy,SLNB)标志着乳腺癌淋巴结外科处理进入微创时代,但其安全有效替代腋窝淋巴结清扫术应建立在规范化操作前提下。中国抗癌协会乳腺癌专业委员会组织业内专家依据循证医学方法制定《乳腺癌前哨淋巴结活检规范化操作指南》,内容涉及SLNB适应证、示踪剂选择与应用、组织标本处理、腋窝SLNB、新辅助治疗与SLNB、内乳SLNB。本指南将为乳腺癌相关医务工作者的临床实践提供有益指导和参考。&nbsp;</span></p>, tagList=[TagDto(tagId=467556, tagName=乳腺癌前哨淋巴结活检)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=42, categoryName=转化医学, tenant=100), CategoryDto(categoryId=69, categoryName=检验病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=21054, categoryName=梅斯医学-乳腺癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4306, appHits=83, showAppHits=0, pcHits=434, showPcHits=4220, likes=0, shares=11, comments=4, approvalStatus=1, publishedTime=Mon Dec 12 21:10:00 CST 2022, publishedTimeString=2022-11-30, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Fri Dec 09 21:12:21 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Sat Jan 06 07:22:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=乳腺癌前哨淋巴结活检规范化操作指南(2022精要版).pdf)])
乳腺癌前哨淋巴结活检规范化操作指南(2022精要版).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2122290, encodeId=e8bc21222909a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36542253479, createdName=zhoulang25, createdTime=Tue Mar 28 17:57:11 CST 2023, time=2023-03-28, status=1, ipAttribution=印第安纳), GetPortalCommentsPageByObjectIdResponse(id=2114856, encodeId=8d9b21148562a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 16 08:15:16 CST 2023, time=2023-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113742, encodeId=8c212113e42a6, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 09 08:57:49 CST 2023, time=2023-02-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2105910, encodeId=ffc42105910c5, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:46:17 CST 2022, time=2022-12-13, status=1, ipAttribution=上海)]
    2023-03-28 zhoulang25 来自印第安纳

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2122290, encodeId=e8bc21222909a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36542253479, createdName=zhoulang25, createdTime=Tue Mar 28 17:57:11 CST 2023, time=2023-03-28, status=1, ipAttribution=印第安纳), GetPortalCommentsPageByObjectIdResponse(id=2114856, encodeId=8d9b21148562a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 16 08:15:16 CST 2023, time=2023-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113742, encodeId=8c212113e42a6, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 09 08:57:49 CST 2023, time=2023-02-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2105910, encodeId=ffc42105910c5, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:46:17 CST 2022, time=2022-12-13, status=1, ipAttribution=上海)]
    2023-02-16 ms2000000607989566 来自河北省

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2122290, encodeId=e8bc21222909a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36542253479, createdName=zhoulang25, createdTime=Tue Mar 28 17:57:11 CST 2023, time=2023-03-28, status=1, ipAttribution=印第安纳), GetPortalCommentsPageByObjectIdResponse(id=2114856, encodeId=8d9b21148562a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 16 08:15:16 CST 2023, time=2023-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113742, encodeId=8c212113e42a6, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 09 08:57:49 CST 2023, time=2023-02-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2105910, encodeId=ffc42105910c5, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:46:17 CST 2022, time=2022-12-13, status=1, ipAttribution=上海)]
    2023-02-09 ms2000000607989566 来自河北省

    非常实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2122290, encodeId=e8bc21222909a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36542253479, createdName=zhoulang25, createdTime=Tue Mar 28 17:57:11 CST 2023, time=2023-03-28, status=1, ipAttribution=印第安纳), GetPortalCommentsPageByObjectIdResponse(id=2114856, encodeId=8d9b21148562a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 16 08:15:16 CST 2023, time=2023-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2113742, encodeId=8c212113e42a6, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Feb 09 08:57:49 CST 2023, time=2023-02-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2105910, encodeId=ffc42105910c5, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:46:17 CST 2022, time=2022-12-13, status=1, ipAttribution=上海)]
    2022-12-13 小明6666 来自上海

    牛逼

    0